Autoimmune Signs in Moroccan Children With Rare Immune Disorders

🩺 Introduction

Some children are born with rare immune system disorders called inborn errors of immunity. This study looked at how often children in Morocco with these disorders also develop autoimmune problems, where the immune system attacks the body. It is not clear whether the study was in people or records.

🔬 What the study did

Researchers reviewed records of children listed in Morocco's national registry for inborn errors of immunity between January 2007 and December 2023. They looked at demographic, clinical, and laboratory information, focusing on autoimmune signs.

📊 What it found

• Of 769 registered patients, 108 (14%) had at least one autoimmune manifestation.
• Consanguinity, or parents being related by blood, was seen in 59 of 108 cases (55%).
• The male-to-female ratio was 1.14.
• Median age at first symptoms was 10 months; median age at diagnosis was 30 months.
• Among 191 autoimmune manifestations, autoimmune cytopenia (low blood cells) was most common at 72%.
• Poly-autoimmunity, meaning more than one autoimmune condition, occurred in 47.3% of affected patients.

💡 What it means

In this group, autoimmune problems were a common added burden for children already living with rare immune disorders. Blood-related autoimmune issues stood out. The findings suggest doctors should consider these immune disorders when children first show autoimmune signs, especially blood problems.

🔍 Study vs. claim

The study describes patterns of autoimmune manifestations in children already diagnosed with inborn errors of immunity. It does not test whether treating autoimmunity prevents or changes these immune disorders.

🚫 What it does NOT show

• It cannot show whether autoimmune signs cause the immune disorders.
• It cannot show how these children responded to any treatment.
• It cannot show whether findings apply outside Morocco.
• It cannot show long-term outcomes beyond the registry period.

📋 Evidence level

A retrospective registry analysis; whether subjects were people or records is not clearly specified.

🎯 Confidence indicator

Confidence: Low to moderate — the study type is not clearly specified, so caution is warranted.

⚖️ How much to trust it

The trust tier is Moderate. A study with an unclear design earns this level because the methods cannot be fully judged.

⚠️ Limitations

• ✅ Study type is not clearly specified.
• ✅ Subjects are not clearly specified.
• ✅ Follow-up duration is not reported.
• ✅ Data come from a single national registry.

❓ Open questions

• How do these children fare over time?
• Do treatments change autoimmune outcomes?
• Do similar patterns appear in other countries?

✅ Your action plan

• ✅ If a child has repeated or unusual autoimmune signs, ask a doctor about immune system evaluation.
• ✅ Keep a simple record of symptoms and dates to share with professionals.
• ✅ Seek care from specialists experienced with rare immune disorders.
• ✅ Discuss any concerns with a qualified professional; no proven human prevention plan exists yet.

🧾 Takeaway

Autoimmune problems, especially blood-related ones, were common in these children with rare immune disorders, but the study design limits firm conclusions.

This summary is for general information only and is not medical advice. Talk to a qualified professional before changing anything about your health.

📚 Source

Autoimmune manifestations in children with inborn errors of immunity in Morocco: A study from the national registry.. Journal of translational autoimmunity. 2025 PubMed